Del.icio.us
Google
Yahoo MyWeb
Facebook
Omeros Overview
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
Our most clinically advanced product candidates are derived from our proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological...More»
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.
Our most clinically advanced product candidates are derived from our proprietary PharmacoSurgery platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Our PharmacoSurgery platform is based on low-dose combinations of therapeutic agents delivered directly to the surgical site throughout the duration of the procedure to preemptively inhibit inflammation and other problems caused by surgical trauma and to provide clinical benefits both during and after surgery.«Less
Key People
Board of Directors
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 02/2007 | Series A | 63M | 80M | |
| 01/2009 | Series B | 3.1M | Unknown |
Products
| Name: | OMS103HP - Arthoscopy |
| Product URL: | http://www.omeros.com/pipeline/arthro.htm |
| Description: | Omeros' lead product candidate, OMS103HP, is in two Phase 3 clinical programs at leading orthopedic sports medicine centers throughout the U.S. and Canada. The first program is evaluating OMS103HP's safety and ability to improve postoperative joint function and reduce pain following arthroscopic anterior cruciate ligament (ACL) reconstruction surgery. The second program is evaluating OMS103HP's safety and ability to reduce pain and improve postoperative joint function following arthroscopic meniscectomy surgery. |
Competitors
Profile
OpinionsRelated Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »
Web Metrics
View All Web Metrics »
| Alexa Rank: | n/a |  |
n/a |
| Yahoo Search Results: | n/a | ||
News & Blogs
View All News »- Latest
- Most Popular
- Submit a Story »
Omeros Gets $25M
Oct 26, 2010 - 0 comments
Mistras Up, Omeros Not On IPO Day
Oct 8, 2009 - 0 comments
Santander, Verisk, Omeros may make $9 billion IPO week
Sep 21, 2009 - 0 comments
More Musty Old IPOs Resurface
May 15, 2009 - 0 comments
Omeros Gets $3.1M
Jan 28, 2009 - 0 comments
Omeros on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...